The endogenous cannabinoid, anandamide regulates anterior pituitary secretion in vitro

Addiction Biology

Volumn 5, Issue 1, 2000, Pages 59-64

  Wenger, Tibor ^a   Jamali, Khalid A ^b   Juanéda, Christian ^b   Bácsy, Ernö ^c   Tramu, Gérard ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LIGAND; LUTEINIZING HORMONE; PROLACTIN; RIMONABANT; RINGER SOLUTION;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL STIMULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CULTURE MEDIUM; HORMONE DETERMINATION; HYPOPHYSIS FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033966238     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210071270     Document Type: Article

References (26)

1. 1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 1965;87:3273-5.
2. 2. Dewey WL. Cannabinoid pharmacology. Pharmacol Rev 1986;38:151-78.
3. 3. Devane WA, Dusarc III FA, Johnson MR, Mevin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-13.
4. 4. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Banner TI. Structure of a cannabinoid receptor and fuctional expression of the cloned cDNA. Nature 1990;346:561-4.
5. 5. Herkenham M, Lynn AB, Little MD et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990;87:1932-6.
6. 6. Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA. Cannabinoid agonists stimulate both receptor-and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 1992;42:838-45.
7. 7. Shire D, Carrilon C, Kaghad M et al. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 1995;270:3726-31.
8. 8. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-5.
9. 9. Devane WA, Hanus L, Breuer A et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;58: 1946-9.
10. 10. Rinaldi-Carmona M, Earth F, Heaulme M et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994;350:240-4.
11. 11. Wenger T, Tóth BE, Martin BR. Effects of anandamide (endogenous cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sci 1995;56:2057-63.
12. 12. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991;11:563-83.
13. 13. Giannikou P, Yiannakakis N, Frangkakis G, Probonas K, Wenger T. Anandamide (endogenous cannabinoid) decreases serum prolactin in pregnant rat. Neuroendocrinol Lett 1995;17:281-7.
14. 14. Wenger T, Jamali KA, Juaneda C, Leonardelli J, Tramu G. Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. Biochcm Bioph Res Com 1997;237:724-8.
15. 9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology 1990;52:316-21.
16. 16. Rettori V, Wenger T, Snyder G, Dalterio S, McCann SM. Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat. Neuroendocrinology 1988;47:498-503.
17. 17. Wenger T, Rettori V, Synder G, Dalterio S, McCann SM. Effects of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle-stimulating hormone secretion in adult male rats. Neuroendocrinology 1987;46:488-93.
18. 18. Di Marzo V, Petrocellis L. The endogenous cannabinoid signaling system: chemistry, biochemistry and physiology. Internet J Sci-Biol Chem 1997;1: 1-33.
19. 19. Felder CC, Nielsen A, Briley EM et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anadamide in brain and peripheral tissues of human and rat. FEBS Lett 1996;393: 231-5.
20. 20. Felder C, Glass M. Cannabinoid receptors and their endogenous agonists. Ann Rev Pharmacol Toxicol 1998;38:179-200.
21. 1 receptor mRNA in the pituitary gland. Neuroendocrinology 1999;70:137-45.
22. 22. Nagy I, Rappay G, Makara GB, Horváth G, Bácsy E, MacLeod RM. Is there a direct correlation between the activities of various lysosomal enzymes and prolactin secretion in the rat anterior pituitary? Endocrinology 1983;112:470-5.
23. 23. Rappay G, Nagy I, Makara GB et al. Inhibition of growth hormone and prolactin secretion by a serine proteinase inhibitor. Life Sci 1984;34:337-44.
24. 24. Axelrod J, Felder CC. Cannabinoid receptors and their endogenous agonist, anandamide. Neurochem Res 1998;23:575-81.
25. 9-tetrahydrocannabinol suppression of prolactin secretion in rat: lack of direct pituitary effect. Endocrinology 1981;109:876-80.
26. 26. Wenger T, Toth BE, Juaneda C, Leonardelli J, Tramu G. The effects of cannabinoids on the regulation of reproduction. Life Sci 1999;65:695-701.